Artelo Biosciences ARTL
NASDAQ ARTL
$2.57 -0.05 (-1.91%)
As of: Oct 21, 2026 · 3:59 PM EDT

Artelo Biosciences (ARTL) Interest Paid (2017)

Updated

Analysis

Artelo Biosciences (ARTL) Interest Paid (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,149.64 Bn 1,118.23 Bn 19.71 Bn -
2 Johnson & Johnson 626.55 Bn 545.08 Bn 17.26 Bn -
3 AbbVie 498.79 Bn 471.91 Bn 12.70 Bn -
4 Merck 371.66 Bn 326.04 Bn 12.21 Bn -
5 Novartis Ag 299.96 Bn 263.95 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 263.22 Bn 236.91 Bn 12.86 Bn 1.07 Bn
7 Amgen 237.03 Bn 192.43 Bn 7.24 Bn -
8 Gilead Sciences 191.20 Bn 165.40 Bn 6.22 Bn -
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn 1.25 Bn
10 Artelo Biosciences 52,200.88 -5.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2017 1,500.00
API Access

Artelo Biosciences Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=ARTL&period=max&api_key=YOUR_API_KEY